Novacyt (FR:ALNOV) has released an update. Novacyt S.A. has provided an update on its liquidity agreement with Invest Securities, revealing that 35,522 shares were bought and 29,221 were sold in
Novacyt (FR:ALNOV) has released an update. Novacyt S.A. has provided an update on its liquidity agreement with Invest Securities, revealing that 35,522 shares were bought and 29,221 were sold in
Novacyt (FR:ALNOV) has released an update. Novacyt S.A., a leading molecular diagnostics company, has appointed Dr. Ian Gilham as a Non-Executive Director to its board. With extensive experience in the
Novacyt (FR:ALNOV) has released an update. Novacyt has achieved EU IVDR accreditation for its Yourgene® Cystic Fibrosis Base assay, marking it as one of the first CF tests to comply
Novacyt (FR:ALNOV) has released an update. Novacyt S.A. has announced the immediate closure of its subsidiary IT-IS International, a manufacturer of rapid-PCR instruments, due to a saturated market and consecutive
Novacyt (FR:ALNOV) has released an update. Novacyt S.A., a French-based international specialist in clinical diagnostics, has reported transactions of ordinary shares through its liquidity agreement with Invest Securities SA, with